Tag: Jan Feijen

March 20, 2017 Off

Kiadis Pharma finds new COO in Jenssen

By Dino Mustafić

Kiadis Pharma, a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders, has appointment Jan Feijen as Chief Operations Officer (COO) effective from April 1, 2017.